DK247485A - Farmaceutisk formulering af et tungtoploeseligt medikament og fremgangsmaade til fremstilling af en saadan formulering - Google Patents

Farmaceutisk formulering af et tungtoploeseligt medikament og fremgangsmaade til fremstilling af en saadan formulering Download PDF

Info

Publication number
DK247485A
DK247485A DK247485A DK247485A DK247485A DK 247485 A DK247485 A DK 247485A DK 247485 A DK247485 A DK 247485A DK 247485 A DK247485 A DK 247485A DK 247485 A DK247485 A DK 247485A
Authority
DK
Denmark
Prior art keywords
formulation
preparing
procedure
long
soluble medicine
Prior art date
Application number
DK247485A
Other languages
English (en)
Other versions
DK164355C (da
DK247485D0 (da
DK164355B (da
Inventor
Paul Jonathan Harrison
John Richard Langridge
Christopher John Potter
Original Assignee
Sterwin Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterwin Ag filed Critical Sterwin Ag
Publication of DK247485D0 publication Critical patent/DK247485D0/da
Publication of DK247485A publication Critical patent/DK247485A/da
Publication of DK164355B publication Critical patent/DK164355B/da
Application granted granted Critical
Publication of DK164355C publication Critical patent/DK164355C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Control Of El Displays (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK247485A 1984-06-04 1985-06-03 Farmaceutisk formulering af et fast tungtoploeseligt laegemiddelstof og fremgangsmaade til fremstilling af en saadan formulering DK164355C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848414221A GB8414221D0 (en) 1984-06-04 1984-06-04 Unit dosage form
GB8414221 1984-06-04

Publications (4)

Publication Number Publication Date
DK247485D0 DK247485D0 (da) 1985-06-03
DK247485A true DK247485A (da) 1985-12-05
DK164355B DK164355B (da) 1992-06-15
DK164355C DK164355C (da) 1992-11-02

Family

ID=10561913

Family Applications (1)

Application Number Title Priority Date Filing Date
DK247485A DK164355C (da) 1984-06-04 1985-06-03 Farmaceutisk formulering af et fast tungtoploeseligt laegemiddelstof og fremgangsmaade til fremstilling af en saadan formulering

Country Status (20)

Country Link
US (1) US4717569A (da)
EP (1) EP0164967B1 (da)
JP (1) JPS611613A (da)
KR (1) KR860000067A (da)
AT (1) ATE56357T1 (da)
AU (1) AU578474B2 (da)
CA (1) CA1242646A (da)
DE (1) DE3579631D1 (da)
DK (1) DK164355C (da)
ES (1) ES8608865A1 (da)
FI (1) FI84783C (da)
GB (1) GB8414221D0 (da)
GR (1) GR851355B (da)
IL (1) IL75372A (da)
MX (1) MX161943A (da)
NO (1) NO166918C (da)
NZ (1) NZ212255A (da)
PH (1) PH22173A (da)
PT (1) PT80584B (da)
ZA (1) ZA854115B (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament
US4833133A (en) * 1986-05-22 1989-05-23 Sterling Drug Inc. Method of regulating fertility in cattle using epostane
US4870068A (en) * 1986-05-22 1989-09-26 Sterling Drug Inc. Method of regulating fertility in swine using epostane
JP2680614B2 (ja) * 1988-08-01 1997-11-19 日清製粉株式会社 ダナゾール組成物
JP2773895B2 (ja) * 1989-04-25 1998-07-09 東京田辺製薬株式会社 ダナゾール組成物
JP2542122B2 (ja) * 1990-04-18 1996-10-09 旭化成工業株式会社 球状核、球形顆粒およびその製造方法
EP0452862B1 (en) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Spherical seed cores, spherical granules and process for production thereof
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5573783A (en) * 1995-02-13 1996-11-12 Nano Systems L.L.C. Redispersible nanoparticulate film matrices with protective overcoats
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
FR2795961B1 (fr) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
JP3386052B2 (ja) * 2001-02-13 2003-03-10 トヨタ自動車株式会社 ポンプ装置
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
FR2842736B1 (fr) * 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
GB2400554B (en) * 2003-04-16 2007-04-18 George Margetts Treatment of angiotensin II-induced cardiovascular disease
US20050089570A1 (en) * 2003-09-26 2005-04-28 Evangeline Cruz Oros push-stick for controlled delivery of active agents
AU2004314693B2 (en) 2003-09-26 2011-04-07 Alza Corporation Drug coating providing high drug loading and methods for providing the same
EP1680094A1 (en) * 2003-09-26 2006-07-19 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
AU2004275835B2 (en) * 2003-09-26 2011-06-23 Alza Corporation Controlled release formulations exhibiting an ascending rate of release
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
FR2885526B1 (fr) * 2005-05-13 2007-07-27 Flamel Technologies Sa Medicament oral a base d'inhibiteur de pompe a protons
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US7632492B2 (en) * 2006-05-02 2009-12-15 Allozyne, Inc. Modified human interferon-β polypeptides
US20080096819A1 (en) * 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
CA2707840A1 (en) * 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
CA2718416C (en) * 2008-03-13 2018-01-02 Mallinckrodt Inc. Multi-function, foot-activated controller for imaging system
MX2011002790A (es) 2008-09-25 2011-04-05 Isp Investments Inc Composiciones de recubrimiento de tabletas con alto contenido de solidos, lisas.
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2012091040A1 (ja) * 2010-12-27 2012-07-05 富田製薬株式会社 製剤用崩壊型核粒子
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB742007A (en) * 1953-04-01 1955-12-14 Smith Kline & French Internat Improvements in or relating to method of forming coated pharmaceutical pellets
GB765086A (en) * 1954-11-19 1957-01-02 Smith Kline & French Internat Anticholinergic preparation
GB785262A (en) * 1955-09-23 1957-10-23 Smith Kline & French Internat Improvements in or relating to hypotensive and sedative preparations
GB844772A (en) * 1956-04-19 1960-08-17 Pfizer & Co C Granular pharmaceutical compositions and process for preparing same
US3328256A (en) * 1963-05-27 1967-06-27 William E Gaunt Spherical beads and their production
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
AT336190B (de) * 1974-07-23 1977-04-25 Hurka Wilhelm Verfahren zur herstellung von mikropellets zur behandlung von erkrankungen des mund- und rachenraumes
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
FR2510582B1 (fr) * 1981-07-30 1986-05-30 Sipsy Steroides esterifies en la position 17 et thio-esterifies en la position 21, leur procede de preparation et leur application comme medicament
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof

Also Published As

Publication number Publication date
FI84783C (fi) 1992-01-27
MX161943A (es) 1991-03-08
DK164355C (da) 1992-11-02
EP0164967B1 (en) 1990-09-12
GR851355B (da) 1985-11-25
DK247485D0 (da) 1985-06-03
NO166918C (no) 1991-09-18
AU578474B2 (en) 1988-10-27
PT80584B (pt) 1987-09-18
FI84783B (fi) 1991-10-15
NO852226L (no) 1985-12-05
PT80584A (en) 1985-07-01
EP0164967A3 (en) 1986-12-30
IL75372A0 (en) 1985-09-29
ZA854115B (en) 1986-01-29
CA1242646A (en) 1988-10-04
FI852236L (fi) 1985-12-05
KR860000067A (ko) 1986-01-25
JPS611613A (ja) 1986-01-07
NZ212255A (en) 1988-06-30
ES8608865A1 (es) 1986-07-16
DE3579631D1 (de) 1990-10-18
PH22173A (en) 1988-06-28
GB8414221D0 (en) 1984-07-11
ES543828A0 (es) 1986-07-16
FI852236A0 (fi) 1985-06-04
NO166918B (no) 1991-06-10
EP0164967A2 (en) 1985-12-18
DK164355B (da) 1992-06-15
US4717569A (en) 1988-01-05
AU4323785A (en) 1985-12-12
IL75372A (en) 1989-08-15
ATE56357T1 (de) 1990-09-15

Similar Documents

Publication Publication Date Title
DK247485A (da) Farmaceutisk formulering af et tungtoploeseligt medikament og fremgangsmaade til fremstilling af en saadan formulering
IL59063A (en) Polymeric diffusion matrix for release of pharmaceutical dosage
PT78732B (de) 13-alpha-alkylgonane deren herstellung und diese enthaltende pharmazeutische praeparate
PH17384A (en) Pharmaceutical compositions containing a corticosteroid substance
DE19975013I1 (de) 2.Oxo-Imidazolidin-Verbindungen Verfahren zu derenHerstellung und pharmazeutische Zusammensetzung
PT76853A (fr) Procede de preparation de compositions pharmaceutiques a base de xylosides et lyxosides de base puriques et pyrimidiques
DE2960968D1 (en) Ethanolamine compounds, processes for their preparation, pharmaceutical preparations containing them and their medicinal use
DK471783D0 (da) Farmaceutisk praeparat og fremgangsmade til fremstilling deraf
LU84492A1 (de) Cumarin-derivate,verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische praeparate
GB1549887A (en) Spiro(isobenzofuran)s a process for their preparation and pharmaceutical preparations comprising them
ZA817395B (en) 1-carboxyalkanoylindoline-2-carboxylic acids,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application
ATE23168T1 (de) 11-beta-aryl-estradiene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
ZA817559B (en) 1-carboxy-azaalkanoylindoline-2-carboxylic acids,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application
ZA801969B (en) 2-aminoalkyl-5-pyridinols,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application
ATE21701T1 (de) Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate.
ATE32073T1 (de) Karbonsaeureamidguanidine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE31534T1 (de) Cyanguanidine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE12486T1 (de) Phenoxy- und thiophenoxyverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
PH18966A (en) 19-nor steroids and 19-nor-d-homosteroids,method of use and pharmaceutical composition thereof
ATE51149T1 (de) Therapeutische anwendung eines indandionderivats und pharmazeutische zusammensetzungen zu ihrer verwendung.

Legal Events

Date Code Title Description
PBP Patent lapsed